Valentyn Shapovalov: Difference between revisions
Expand verified author records and publication-linked research network |
Add verified public Google Scholar profile |
||
| Line 4: | Line 4: | ||
* [https://orcid.org/0000-0002-9329-0195 ORCID 0000-0002-9329-0195]. | * [https://orcid.org/0000-0002-9329-0195 ORCID 0000-0002-9329-0195]. | ||
* [https://www.researchgate.net/profile/Valentyn-Shapovalov ResearchGate profile]. | * [https://www.researchgate.net/profile/Valentyn-Shapovalov ResearchGate profile]. | ||
* [https://scholar.google.com/citations?user=u4_a__kAAAAJ&hl=en Google Scholar profile]. | |||
== Dated institutional context == | == Dated institutional context == | ||
Revision as of 23:55, 11 November 2026
Valentyn Shapovalov is a contributor to the publications documented in this wiki. Also appears as Valentin Shapovalov; Ukrainian: Шаповалов Валентин Валерійович. He is distinct from Valerii Shapovalov.
Identity and public profiles
Dated institutional context
The SRUMPL management page, dated 16 May 2026, identifies him as president. This is a dated institutional record, not a role inferred from publication initials.
SRUMPL management record and the specific publications below provide the source context.
Selected publication connections
- With Andriy Gudzenko, Valeriy Shapovalov and Viktoriya Shapovalova: the 2021 forensic-pharmacy study of complaints about medicine provision for privileged patient categories, DOI 10.31435/rsglobal_sr/30042021/7517.
- With Oleksandr Veits, Valerii Shapovalov and Andrii Diachenko: US drug-trafficking policy and its possible relevance for Ukraine (23 September 2025), publisher record.
- With Andrii Diachenko and Anatolii Derkach: healthcare reform and legal relationships in the United States and Ukraine, publisher record. The landing page gives 13 February 2026; an inconsistent received date in the PDF should not be substituted.
Shared conceptual publications
The publisher records list this author among the six coauthors of The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration (12 December 2025) and Vision 2035 – Medico-Pharmaceutical Law for Human Security (6 March 2026). These bylines apply to those editions, not automatically to every later revision or conceptual article.
- 2025 monograph, DOI 10.53933/3qgntf55.
- 2026 book, DOI 10.53933/b91avw28.
Reading the record
Publication coauthorship, institutional office and contribution to an individual concept are different relationships. See Research network for dated, work-specific connections and People and attribution for editorial principles. Profile databases can contain duplicate records or name variants; the ORCID identifier is an identity key, not proof that every listed claim has been independently audited.